These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21129837)

  • 101. Central nerve block and thromboprophylaxis.
    Dolenska S
    Br J Anaesth; 1999 Sep; 83(3):534-5; author reply 535-6. PubMed ID: 10655941
    [No Abstract]   [Full Text] [Related]  

  • 102. Central nerve block and thromboprophylaxis.
    Gorton P
    Br J Anaesth; 1999 Sep; 83(3):534; author reply 535-6. PubMed ID: 10655940
    [No Abstract]   [Full Text] [Related]  

  • 103. Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality.
    Meakins JL; Christou NV; Bohnen J; MacLean LD
    Br Med J (Clin Res Ed); 1982 Oct; 285(6349):1207-8. PubMed ID: 6812812
    [No Abstract]   [Full Text] [Related]  

  • 104. Delayed immunological reaction to Integra™ skin graft.
    Flynn A; Kilmartin D; Phelan S; McMenamin M; Kelly J; Laing ME
    Clin Exp Dermatol; 2019 Aug; 44(6):714-716. PubMed ID: 30675916
    [No Abstract]   [Full Text] [Related]  

  • 105. Delayed hypersensitivity in mice to dextran.
    Crowle AJ; Hu CC
    Int Arch Allergy Appl Immunol; 1967; 31(2):123-44. PubMed ID: 6020899
    [No Abstract]   [Full Text] [Related]  

  • 106. Necrobiotic palisading granulomas associated with face cream injections.
    Mir RN
    Plast Reconstr Surg; 1996 Apr; 97(4):871-2. PubMed ID: 8628791
    [No Abstract]   [Full Text] [Related]  

  • 107. The role of the macrophage in delayed hypersensitivity.
    Dumonde DC
    Br Med Bull; 1967 Jan; 23(1):9-14. PubMed ID: 5342388
    [No Abstract]   [Full Text] [Related]  

  • 108. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P; Duraj I; Szlagowska L; Ciastkowska A; Broncel M
    Pol Merkur Lekarski; 2014 Nov; 37(221):261-4. PubMed ID: 25546985
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Successful desensitization with un-fractionated heparin in a patient with heparin allergy and tolerance to fondaparinux.
    Kavut AB; Koca E
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):162-6. PubMed ID: 22830297
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report.
    Kargiotis K; Katsiki N; Athyros VG; Giouleme O; Patsiaoura K; Katsiki E; Mikhailidis DP; Karagiannis A
    Curr Vasc Pharmacol; 2014 May; 12(3):505-11. PubMed ID: 24805248
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Novel treatments with small molecules in psoriatic arthritis.
    Hansen RB; Kavanaugh A
    Curr Rheumatol Rep; 2014; 16(9):443. PubMed ID: 25027606
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Safety of fondaparinux versus enoxaparin after TKA in Japanese patients.
    Hosaka K; Saito S; Ishii T; Sumino T; Ryu K; Suzuki G; Suzuki T; Tokuhashi Y
    Orthopedics; 2013 Apr; 36(4):e428-33. PubMed ID: 23590781
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience.
    Sunbul M; Oguz M; Dogan Z; Atas H; Bozbay M; Cincin A; Agirbasli M
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):454-459. PubMed ID: 26566667
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Association of musculoskeletal complaints and gliptin use: review of spontaneous reports.
    Tarapués M; Cereza G; Figueras A
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1115-8. PubMed ID: 23960039
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
    Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study.
    Hyogo H; Ikegami T; Tokushige K; Hashimoto E; Inui K; Matsuzaki Y; Tokumo H; Hino F; Tazuma S
    Hepatol Res; 2011 Nov; 41(11):1057-65. PubMed ID: 21951922
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 118. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.